F.D.A. Faces Upset Over Denials of New Drugsnews2026-03-05T19:26:40+00:00March 5th, 2026|The New York Times|
La búsqueda de China de conquistar el envejecimientonews2025-11-10T18:24:09+00:00November 10th, 2025|The New York Times|
Inside China’s Quest to Defy Aging with Longevity Labs and ‘Immortality Islands’news2025-11-08T10:55:21+00:00November 8th, 2025|The New York Times|
F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugsnews2025-10-29T20:07:07+00:00October 29th, 2025|The New York Times|
Trump’s Pharma Tariffs Spare Richest Drugmakersnews2025-09-26T23:05:47+00:00September 26th, 2025|The New York Times|
U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on Chinanews2025-09-10T13:52:52+00:00September 10th, 2025|The New York Times|
China’s Biotech Is Cheaper and Faster Than America’snews2025-08-17T05:00:05+00:00August 17th, 2025|The New York Times|
Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidysnews2025-07-19T00:53:42+00:00July 19th, 2025|The New York Times|
Kennedy Says ‘Charlatans’ Are No Reason to Block Unproven Stem Cell Treatmentsnews2025-06-05T16:07:54+00:00June 5th, 2025|The New York Times|
Ramaswamy Has a High-Profile Perch and a Raft of Potential Conflictsnews2025-01-15T22:04:34+00:00January 15th, 2025|The New York Times|
